- Home
- VERA vs ASTH Comparison
VERA vs ASTH Comparison
Compare VERA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- ASTH
- Stock Information
- Founded
- VERA 2016
- ASTH 1994
- Country
- VERA United States
- ASTH United States
- Employees
- VERA N/A
- ASTH N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- VERA Health Care
- ASTH Consumer Discretionary
- Exchange
- VERA Nasdaq
- ASTH Nasdaq
- Market Cap
- VERA 2.0B
- ASTH 1.7B
- IPO Year
- VERA 2021
- ASTH N/A
- Fundamental
- Price
- VERA $23.82
- ASTH $24.90
- Analyst Decision
- VERA Buy
- ASTH Strong Buy
- Analyst Count
- VERA 8
- ASTH 8
- Target Price
- VERA $64.63
- ASTH $53.29
- AVG Volume (30 Days)
- VERA 1.4M
- ASTH 272.7K
- Earning Date
- VERA 08-07-2025
- ASTH 08-06-2025
- Dividend Yield
- VERA N/A
- ASTH N/A
- EPS Growth
- VERA N/A
- ASTH N/A
- EPS
- VERA N/A
- ASTH 0.73
- Revenue
- VERA N/A
- ASTH $2,250,574,000.00
- Revenue This Year
- VERA N/A
- ASTH $41.46
- Revenue Next Year
- VERA N/A
- ASTH $23.97
- P/E Ratio
- VERA N/A
- ASTH $34.00
- Revenue Growth
- VERA N/A
- ASTH 54.81
- 52 Week Low
- VERA $18.53
- ASTH $23.12
- 52 Week High
- VERA $51.61
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- VERA 52.93
- ASTH 47.07
- Support Level
- VERA $22.57
- ASTH $24.13
- Resistance Level
- VERA $24.58
- ASTH $25.80
- Average True Range (ATR)
- VERA 1.22
- ASTH 1.25
- MACD
- VERA 0.14
- ASTH 0.13
- Stochastic Oscillator
- VERA 69.80
- ASTH 38.05
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.